Pricing Log in Create free account

Greenwich LifeSciences, Inc. (GLSI) vs Lexeo Therapeutics, Inc. (LXEO)

Greenwich LifeSciences, Inc. and Lexeo Therapeutics, Inc. are both Biotechnology companies. Greenwich LifeSciences, Inc. and Lexeo Therapeutics, Inc. are of similar size ($226.6M and $224.9M). Across the 10 metrics below, Greenwich LifeSciences, Inc. leads on 5 and Lexeo Therapeutics, Inc. on 5.

Valuation

Metric GLSI LXEO Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 68.25 0.96 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (10.58%) (43.56%) (33.15%)
Free cash flow yield (5.87%) (39.24%) (25.50%)

Profitability

Metric GLSI LXEO Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (986.31%) (46.76%) (56.36%)
Return on assets (374.46%) (40.50%) (48.04%)
Return on invested capital 0.00% (253.48%) 0.00%

Growth

Metric GLSI LXEO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (18.18%) 39.81% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GLSI LXEO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 13.89 4.72
Net debt to EBITDA 0.32 1.67 0.96

Dividend

Metric GLSI LXEO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GLSI LXEO Biotechnology median
Market cap 224.87m 226.56m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack